|
Re: Zenith and Breast Cancer
|
6
|
Zenith Epigenetics
|
Mar 11, 2018 02:36PM
|
|
Resverlogix Commences Phase 3 Clinical Trial BETonMACE With Apabetalone
|
6
|
Resverlogix Corp.
|
Oct 26, 2015 07:28AM
|
|
FDA halts use of antibody drugs that don't work vs. omicron
|
6
|
Resverlogix Corp.
|
Jan 24, 2022 06:41PM
|
|
Re: When in Rome.......ESC presentations from August now online
|
6
|
Resverlogix Corp.
|
Sep 26, 2016 09:36AM
|
|
A bit dated but still relevant article
|
6
|
Zenith Epigenetics
|
Jun 15, 2018 07:19PM
|
|
Don on CTV Calgary News 6:18pm
|
6
|
Resverlogix Corp.
|
Jan 24, 2022 08:24PM
|
|
Re: Resverlogix and Zenith AGMs
|
6
|
Resverlogix Corp.
|
Aug 23, 2016 10:38AM
|
|
Awaken Dormant DNA, Epigenetically - Article in GEN
|
6
|
Zenith Epigenetics
|
Jan 12, 2018 06:03PM
|
|
New docs on SEDAR
|
6
|
Zenith Epigenetics
|
Jan 01, 2016 10:27AM
|
|
Clovis' Rubracra
|
6
|
Zenith Epigenetics
|
Oct 03, 2018 01:02PM
|
|
Re: ESC Poster on Vascular Inflammation, Calcification and Plaque Vulnerability
|
7
|
Resverlogix Corp.
|
Sep 03, 2019 10:54AM
|
|
PAH Plans get a write up in Pulmonary Hypertension News
|
7
|
Resverlogix Corp.
|
May 21, 2019 08:34AM
|
|
Beacon report spreading
|
7
|
Resverlogix Corp.
|
Dec 07, 2017 08:06PM
|
|
Re: AHA NEWS
|
7
|
Resverlogix Corp.
|
Sep 23, 2019 07:25PM
|
|
Zenith Special Meeting Jun 30 10am MDT
|
7
|
Resverlogix Corp.
|
Jun 30, 2015 03:42PM
|
|
AGM - High Level Summary
|
7
|
Zenith Epigenetics
|
Jan 07, 2016 03:54PM
|
|
Dr Johann
|
7
|
Resverlogix Corp.
|
Apr 04, 2016 04:33PM
|
|
Rodman and Renshaw Conf
|
7
|
Resverlogix Corp.
|
Sep 13, 2016 04:04PM
|
|
Re: Trial started
|
7
|
Resverlogix Corp.
|
Jan 18, 2022 08:13AM
|
|
Zenith shares revalued at Investorline
|
7
|
Zenith Epigenetics
|
Sep 15, 2018 09:10AM
|
